• Bacterial infections

Cleocin Generic Name & Formulations

General Description

Clindamycin (as HCl) 75mg+, 150mg+, 300mg; caps; +contains tartrazine.

Pharmacological Class


How Supplied

Caps—100; Granules (100mL)—1; Inj (2mL, 4mL, 6mL vials)—25


Generic Availability


Cleocin Indications


Serious susceptible infections where less toxic antibiotics are inappropriate, including respiratory, skin and soft tissue, septicemia, intraabdominal, female pelvic or genital; bone and joint (inj).

Cleocin Dosage and Administration


Take with full glass of water. Serious: 150–300mg every 6hrs. More severe: 300–450mg every 6hrs. Beta-hemolytic streptococcal infections: treat for at least 10 days.


Take with full glass of water. Serious: 8–16mg/kg per day. More severe: 16–20mg/kg per day. Divide into 3–4 equal doses. Beta-hemolytic streptococcal infections: treat for at least 10 days.

Cleocin Contraindications

Not Applicable

Cleocin Boxed Warnings

Boxed Warning

C. difficile-associated diarrhea.

Cleocin Warnings/Precautions


Risk of C. difficile-associated diarrhea; discontinue and treat if colitis is suspected or confirmed. Reserve use for serious infections. Not for treatment of meningitis. Permanently discontinue if severe hypersensitivity reactions occur. Allergy. Asthma (75mg, 150mg caps). GI disease (esp. colitis). Atopy. Monitor blood, renal, and hepatic function in long-term use and in children. IV: Gasping syndrome (neonates, infants). Elderly. Pregnancy. Nursing mothers: consider alternative drug or monitor breast-fed infant for GI effects.

Cleocin Pharmacokinetics

See Literature

Cleocin Interactions


May potentiate neuromuscular blocking agents; caution. May be potentiated by strong CYP3A4 inhibitors; monitor. May be antagonized by strong CYP3A4 inducers (eg, rifampicin); monitor. May antagonize erythromycin; avoid. Antiperistaltic agents may worsen colitis.

Cleocin Adverse Reactions

Adverse Reactions

Pseudomembranous colitis, C. difficile-associated diarrhea, nausea, vomiting, abdominal pain, dysguesia, rash, pruritus, angioedema, anaphylaxis, jaundice, acute kidney injury, blood dyscrasias, polyarthritis, severe skin reactions (eg, toxic epidermal necrolysis, erythema multiforme, drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome).

Cleocin Clinical Trials

See Literature

Cleocin Note

Not Applicable

Cleocin Patient Counseling

See Literature